Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab

AIMS: Guidelines recommend targeting non-high-density lipoprotein cholesterol to reduce cardiovascular risk. We assessed the impact of baseline triglycerides on non-high-density lipoprotein cholesterol goal attainment in 10 phase 3 trials with alirocumab versus control (n = 4983). METHODS: Trials we...

Descripción completa

Detalles Bibliográficos
Autores principales: Vallejo-Vaz, Antonio J, Leiter, Lawrence A, Del Prato, Stefano, Taskinen, Marja-Riitta, Müller-Wieland, Dirk, Bujas-Bobanovic, Maja, Letierce, Alexia, Mandel, Jonas, Samuel, Rita, Ray, Kausik K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Full Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549294/
https://www.ncbi.nlm.nih.gov/pubmed/32089006
http://dx.doi.org/10.1177/2047487320905185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549294/
https://www.ncbi.nlm.nih.gov/pubmed/32089006
http://dx.doi.org/10.1177/2047487320905185

Ejemplares similares